Back
SPDR® S&P Emerging Asia Pacific ETF Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
47
GMF
SPDR® S&P Emerging Asia Pacific ETF
Last Price:
117.46
Seasonality Move:
1.26%
Sell
25
DRUG
Bright Minds Biosciences
Last Price:
43.34
Seasonality Move:
-15.89%
Sell
47
SPDR® S&P Emerging Asia Pacific ETF (GMF)
is a Sell
Is SPDR® S&P Emerging Asia Pacific ETF a Buy, Sell or Hold?
- The current SPDR® S&P Emerging Asia Pacific ETF [GMF] share price is $117.39. The Score for GMF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- GMF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG] share price is $44.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GMF Stock Price Chart
What is SPDR® S&P Emerging Asia Pacific ETF's stock price today?
-
The SPDR® S&P Emerging Asia Pacific ETF share price today is $117.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMF is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $44.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
GMF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.18 | Sell |
Relative Strength Index (14 RSI): | 44 | Sell |
Chaikin Money Flow: | 2352 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (116.74 - 121.6) | Sell |
Bollinger Bands (100): | (110.64 - 121.98) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.5 | Buy |
Relative Strength Index (14 RSI): | 58.93 | Buy |
Chaikin Money Flow: | 115403 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.12 - 49.42) | Buy |
Bollinger Bands (100): | (-5.11 - 34.85) | Buy |
GMF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 116.97 | Buy |
20-day SMA: | 118.63 | Sell |
50-day SMA: | 121.19 | Sell |
200-day SMA: | 111.71 | Buy |
8-day EMA: | 117.12 | Buy |
20-day EMA: | 118.27 | Sell |
50-day EMA: | 118.74 | Sell |
200-day EMA: | 112.71 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.17 | Buy |
20-day SMA: | 42.3 | Buy |
50-day SMA: | 28.61 | Buy |
200-day SMA: | 8.06 | Buy |
8-day EMA: | 39.27 | Buy |
20-day EMA: | 39.13 | Buy |
50-day EMA: | 31.07 | Buy |
200-day EMA: | 12.97 | Buy |
SPDR® S&P Emerging Asia Pacific ETF Earnings Growth & GMF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SPDR® S&P Emerging Asia Pacific ETF Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |